| Ident. | Authors (with country if any) | Title |
|---|
| 000096 |
Iris Trinkler [France] ; Laurent Cleret De Langavant [France] ; Anne-Catherine Bachoud-Levi [France] | Joint recognition-expression impairment of facial emotions in Huntington's disease despite intact understanding of feelings |
| 000113 |
M. Jaber [France] ; M. Benoit-Marand [France] ; L. Prestoz [France] ; A. Gaillard [France] | Cell transplantation in the damaged adult brain |
| 000232 |
Sophie Schumm [France] ; Claude Sebban [France] ; Charles Cohen-Salmon [France] ; Jacques Callebert [France] ; Jean-Marie Launay [France] ; Jean-Louis Golmard [France] ; Lydie Boussicault [France] ; Isabelle Petropoulos [France] ; Audrey Hild [France] ; Estelle Rousselet [France] ; Annick Prigent [France] ; Bertrand Friguet [France] ; Jean Mariani [France] ; Etienne C. Hirsch [France] | Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine |
| 000237 |
G. Madeo [Italie] ; G. Martella [Italie] ; T. Schirinzi [Italie] ; G. Ponterio [Italie] ; J. Shen [États-Unis] ; P. Bonsi [Italie] ; A. Pisani [Italie] | ABERRANT STRIATAL SYNAPTIC PLASTICITY IN MONOGENIC PARKINSONISMS |
| 000314 |
Sylvia Navailles [France] ; Philippe De Deurwaerdere [France] | Presynaptic control of serotonin on striatal dopamine function |
| 000465 |
Kwamivi Dzahini [France] ; Christine Dentresangle [France] ; Marion Le Cavorsin [France] ; Anne Bertrand [France] ; Isabelle Detraz [France] ; Marc Savasta [France] ; Vincent Leviel [France] | Pre-synaptic glutamate-induced activation of DA release in the striatum after partial nigral lesion |
| 000484 |
Dawn M. Eagle [Royaume-Uni] ; Christelle Baunez [France] | Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition |
| 000490 |
Peter Redgrave [Royaume-Uni] ; Manuel Rodriguez [Espagne] ; Yoland Smith [États-Unis] ; Maria C. Rodriguez-Oroz [Espagne] ; Stephane Lehericy [France] ; Hagai Bergman [Israël] ; Yves Agid [France] ; Mahlon R. Delong [États-Unis] ; Jose A. Obeso [Espagne] | Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease |
| 000507 |
A. Faure [France] ; P. Leblanc-Veyrac [France] ; N. El Massioui [France] | DOPAMINE AGONISTS INCREASE PERSEVERATIVE INSTRUMENTAL RESPONSES BUT DO NOT RESTORE HABIT FORMATION IN A RAT MODEL OF PARKINSONISM |
| 000578 |
Olivier Berton [États-Unis] ; Céline Guigoni [France] ; QIN LI [France] ; Bernard H. Bioulac [France] ; Incarnation Aubert [France] ; Christian E. Gross [France] ; Ralph J. Dileone [États-Unis] ; Eric J. Nestler [États-Unis] ; Erwan Bezard [France, République populaire de Chine] | Striatal Overexpression of ΔJunD Resets L-DOPA-Induced Dyskinesia in a Primate Model of Parkinson Disease |
| 000607 |
Dario Cuomo [France, Italie] ; Giuseppina Martella [Italie] ; Emanuela Barabino [France] ; Paola Platania [Italie] ; Daniela Vita [Italie] ; Graziella Madeo [Italie] ; Chelliah Selvam [France] ; Cyril Goudet [France] ; Nadia Oueslati [France] ; Jean-Philippe Pin [France] ; Francine Acher [France] ; Antonio Pisani [Italie] ; Corinne Beurrier [France] ; Christophe Melon [France] ; Lydia Kerkerian-Le Goff [France] ; Paolo Gubellini [France] | Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum : implications for Parkinson's disease treatment |
| 000651 |
M. Guthrie [États-Unis, France] ; C. E. Myers [États-Unis] ; M. A. Gluck [États-Unis] | A neurocomputational model of tonic and phasic dopamine in action selection : A comparison with cognitive deficits in Parkinson's disease |
| 000692 |
Erwan Bezard [France] | L-dopa, un jour et pour toujours |
| 000718 |
Anthony P. Nicholas [États-Unis] ; Farah D. Lubin [États-Unis] ; Penelope J. Hallett [États-Unis] ; Padmapriya Vattem [États-Unis] ; Paula Ravenscroft [Royaume-Uni] ; Erwan Bezard [France] ; SHAOBO ZHOU [Royaume-Uni] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada] ; J. David Sweatt [États-Unis] ; David G. Standaert [États-Unis] | Striatal histone modifications in models of levodopa-induced dyskinesia |
| 000727 |
Juan Esteban Ferrario [France] ; Argelia Esperanza Rojas-Mayorquin [France] ; Marisa Saldana-Ortega [France] ; Cristiane Salum [France] ; Margarete Zanardo Gomes [France] ; Stéphane Hunot [France] ; Rita Raisman-Vozari [France] | Pleiotrophin receptor RPTP-ζ/β expression is up-regulated by L-DOPA in striatal medium spiny neurons of parkinsonian rats |
| 000737 |
Dieter Scheller [Allemagne] ; Christine Stichel-Gunkel [Allemagne] ; Hermann Lübbert [Allemagne] ; Gregory Porras [France] ; Paula Ravenscroft [Royaume-Uni] ; Michael Hill [Royaume-Uni] ; Erwan Bezard [France, Royaume-Uni] | Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson's disease |
| 000742 |
Daniel Alvarez-Fischer [France] ; Serge Guerreiro [France] ; Stephane Hunot [France] ; Francoise Saurini [France] ; Marc Marien [France] ; Pierre Sokoloff [France] ; Etienne C. Hirsch [France] ; Andreas Hartmann [France] ; Patrick P. Michel [France] | Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid |
| 000745 |
Carine Chassain [France] ; Guy Bielicki [France] ; Elodie Durand [France] ; Stéphane Lolignier [France] ; Fatma Essafi [Tunisie] ; Amidou Traore [France] ; Franck Durif [France] | Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse |
| 000748 |
Charlotte Laloux [France] ; Philippe Derambure [France] ; Alexandre Kreisler [France] ; Elise Houdayer [France] ; Servane Brueziere [France] ; Régis Bordet [France] ; Alain Destée [France] ; Christelle Monaca [France] | MPTP-treated mice : long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations |
| 000760 |
Nathalie Thiriet [France] ; Lahouari Amar [France] ; Xauier Toussay [France] ; Virginie Lardeux [France] ; Bruce Ladenheim [États-Unis] ; Kevin G. Becker [États-Unis] ; Jean Lud Cadet [États-Unis] ; Marcello Solinas [France] ; Mohamed Jaber [France] | Environmental enrichment during adolescence regulates gene expression in the striatum of mice |
| 000772 |
Stéphane Woerly [France] ; Sébastien Fort [France] ; Isabelle Pignot-Paintrand [France] ; Cécile Cottet [France] ; Carole Carcenac [France] ; Marc Savasta [France] | Development of a Sialic Acid-Containing Hydrogel of Poly[N-(2-hydroxypropyl) methacrylamide] : Characterization and Implantation Study |
| 000850 |
Elvira De Leonibus [Italie] ; Tiziana Pascucci [Italie] ; Sebastien Lopez [France] ; Alberto Oliverio [Italie] ; Marianne Amalric [France] ; Andrea Mele [Italie] | Spatial deficits in a mouse model of Parkinson disease |
| 000851 |
Elvira De Leonibus [Italie] ; Tiziana Pascucci [Italie] ; Sebastien Lopez [France] ; Alberto Oliverio [Italie] ; Marianne Amalric [France] ; Andrea Mele [Italie] | Spatial deficits in a mouse model of Parkinson disease |
| 000866 |
Constance Hammond [France] ; Hagai Bergman [Israël] ; Peter Brown [Royaume-Uni] | Pathological synchronization in Parkinson's disease : networks, models and treatments |
| 000930 |
J.-C. Corvol [France] ; J.-A. Girault [France] ; D. Herve [France] | Rôle et régulation du récepteur D1 de la dopamine dans le striatum : implications dans les dyskinésies de la maladie de Parkinson |
| 000A88 |
Giinter U. Höglinger [France, Allemagne] ; Annie Lannuzel [France] ; Myriam Escobar Khondiker [France, Allemagne] ; Patrick P. Michel [France] ; Charles Duyckaerts [France] ; Jean Feger [France] ; Pierre Champy [France] ; Annick Prigent [France] ; Fadia Medja [France] ; Anne Lombes [France] ; Wolfgang H. Oertel [Allemagne] ; Merle Ruberg [France] ; Etienne C. Hirsch [France] | The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy |
| 000A91 |
D. Centonze [Italie] ; P. Gubellini [France] ; S. Rossi [Italie] ; B. Picconi [Italie] ; A. Pisani [Italie] ; G. Bernardi [Italie] ; P. Calabresi [Italie] ; C. Baunez [France] | Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism |
| 000B16 |
Irene R. E. Taravini [Argentine] ; Juan E. Ferrario [France] ; Jean Delbe [France] ; Laure Ginestet [France] ; Thomas Debeir [France] ; José Courty [France] ; M. Gustavo Murer [Argentine] ; Oscar S. Gershanik [Argentine] ; Rita Raisman-Vozari [France] | Immunodetection of heparin-binding growth associated molecule (pleiotrophin) in striatal intemeurons |
| 000B46 |
I. J. Bohr [Royaume-Uni] ; M. A. Ray [Royaume-Uni] ; J. M. Mcintosh [États-Unis] ; S. Chalon [France] ; D. Guilloteau [France] ; I. G. Mckeith [Royaume-Uni] ; R. H. Perry [Royaume-Uni] ; F. Clementi [Italie] ; E. K. Perry [Royaume-Uni] ; J. A. Court [Royaume-Uni] ; M. A. Piggott [Royaume-Uni] | Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases : An autoradiography study using [125I]α-conotoxinMII in the striatum and thalamus |
| 000C30 |
Christophe Jollivet [France] ; Anne Aubert-Pouessel [France] ; Anne Clavreul [France] ; Marie-Claire Venier-Julienne [France] ; Claudia N. Montero-Menei [France] ; Jean-Pierre Benoit [France] ; Philippe Menei [France] | Long-term effect of intra-striatal glial cell line-derived neurotrophic factor-releasing microspheres in a partial rat model of Parkinson's disease |
| 000C42 |
Wassilios Meissner [Allemagne, France] ; Daniel Harnack [Allemagne] ; Nora Hoessle [Allemagne] ; Erwan Bezard [France] ; Christine Winter [Allemagne] ; Rudolf Morgenstern [Allemagne] ; Andreas Kupsch [Allemagne] | High frequency stimulation of the entopeduncular nucleus has no effect on striatal dopaminergic transmission |
| 000C53 |
Juan E. Ferrario [Argentine] ; Irene R. E. Taravini [Argentine] ; Sophie Mourlevat [France] ; Andrea Stefano [Argentine] ; Marina A. Delfino [Argentine] ; Rita Raisman-Vozari [France] ; M. Gustavo Murer [Argentine] ; Merle Ruberg [France] ; Oscar Gershanik [Argentine] | Differential gene expression induced by chronic levodopa treatment in the striatum of rats with lesions of the nigrostriatal system |
| 000C54 |
D. Centonze [Italie] ; P. Gubellini [Italie, France] ; A. Usiello [France] ; S. Rossi [Italie] ; A. Tscherter [Italie] ; E. Bracci [Italie, Royaume-Uni] ; E. Erbs [France] ; N. Tognazzi [France] ; G. Bernardi [Italie] ; A. Pisani [Italie] ; P. Calabresi [Italie] ; E. Borrelli [France] | Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum |
| 000D09 |
B. Dubois [France] ; R. Beato [France] ; J.-M. Villalpando [France] | L'évaluation neuropsychologique peut contribuer au diagnostic des maladies du mouvement |
| 000D31 |
Stéphane Thobois [France] ; Maria-Joao Ribeiro [France] ; Ebba Lohmann [France] ; Alexandra Dürr [France] ; Pierre Pollak [France] ; Olivier Rascol [France] ; Stéphane Guillouet [France] ; Elizabeth Chapoy [France] ; Nicolas Costes [France] ; Yves Agid [France] ; Philippe Remy [France] ; Alexis Brice [France] ; Emmanuel Broussolle [France] | Young-onset Parkinson disease with and without parkin gene mutations: A fluorodopa F 18 positron emission tomography study |
| 000D35 |
Guillaume Hebert [France] ; Josette Arsaut [France] ; Robert Dantzer [France] ; Jacques Demotes-Mainard [France] | Time-course of the expression of inflammatory cytokines and matrix metalloproteinases in the striatum and mesencephalon of mice injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a dopaminergic neurotoxin |
| 000D48 |
Erwan Bezard [France] ; Christian E. Gross [France] ; Jonathan M. Brotchie [Canada] | Presymptomatic compensation in Parkinson's disease is not dopamine-mediated |
| 000D51 |
Christian E. Gross [France] ; Paula Ravenscroft [France] ; Sandra Dovero [France] ; Mohamed Jaber [France] ; Bernard Bioulac [France] ; Erwan Bezard [France] | Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice |
| 000D71 |
Mauro Maccarrone [Italie] ; Paolo Gubellini [France, Italie] ; Monica Bari [Italie] ; Barbara Picconi [Italie] ; Natalia Battista [Italie] ; Diego Centonze [Italie] ; Giorgio Bernardi [Italie] ; Alessandro Finazzi-Agro [Italie] ; Paolo Calabresi [Italie] | Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism |
| 000D85 |
Céline Perier [France] ; Concepcio Marin [Espagne] ; Anna Jimenez [Espagne] ; Mercè Bonastre [Espagne] ; Eduardo Tolosa [Espagne] ; Etienne C. Hirsch [France] | Effect of subthalamic nucleus or entopeduncular nucleus lesion on levodopa-induced neurochemical changes within the basal ganglia and on levodopa-induced motor alterations in 6-hydroxydopamine-lesioned rats |
| 000D99 |
Karine Parain [France] ; Céline Hapdey [France] ; Estelle Rousselet [France] ; Véronique Marchand [France] ; Bernard Dumery [France] ; Etienne C. Hirsch [France] | Cigarette smoke and nicotine protect dopaminergic neurons against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Parkinsonian toxin |
| 000E01 |
S. Thobois [France] ; V. Fraix [France] ; M. Savasta [France] ; N. Costes [France] ; P. Pollak [France] ; P. Mertens [France] ; A. Koudsie [France] ; D. Le Bars [France] ; A. L. Benabid [France] ; E. Broussolle [France] | Chronic subthalamic nucleus stimulation and striatal d2 dopamine receptors in Parkinson's disease: A [11C]-raclopride PET study |
| 000E09 |
Carine Cleren [France] ; Bertrand Naudin [France] ; Jean Costentin [France] | Apparent opposite effects of tetrabenazine and reserpine on the toxic effects of 1-methyl-4-phenylpyridinium or 6-hydroxydopamine on nigro-striatal dopaminergic neurons |
| 000E93 |
Stéphanie Barc [France] ; Guylène Page [France] ; Laurence Barrier [France] ; Lucette Garreau [France] ; Denis Guilloteau [France] ; Bernard Fauconneau [France] ; Sylvie Chalon [France] | Relevance of different striatal markers in assessment of the MPP+-induced dopaminergic nigrostriatal injury in rat |
| 000E95 |
T. Breidert [France] ; J. Callebert [France] ; M. T. Heneka [Allemagne] ; G. Landreth [États-Unis] ; J. M. Launay [France] ; E. C. Hirsch [France] | Protective action of the peroxisome proliferator-activated receptor-γ agonist pioglitazone in a mouse model of Parkinson's disease |
| 000E98 |
Marie Sarazin [France] ; Bernard Deweer [France] ; Angela Merkl [France] ; Natalia Von Poser [France] ; Bernard Pillon [France] ; Bruno Dubois [France] | Procedural learning and striatofrontal dysfunction in Parkinson's disease |
| 000F46 |
I. Ghorayeb [France] ; P. O. Fernagut [France] ; N. Stefanova [Autriche] ; G. K. Wenning [Autriche] ; B. Bioulac [France] ; F. Tison [France] | Dystonia is predictive of subsequent altered dopaminergic responsiveness in a chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine + 3-nitropropionic acid model of striatonigral degeneration in monkeys |
| 000F56 |
Yoshimi Misu [Japon] ; Nobuya Furukawa [Japon] ; Nobutaka Arai [Japon] ; Takeaki Miyamae [Japon] ; Yoshio Goshima [Japon] ; Kiyohide Fujita [Japon] | DOPA causes glutamate release and delayed neuron death by brain ischemia in rats |
| 001022 |
M. Sarazin [France] ; B. Deweer [France] ; B. Pillon [France] ; A. Merkl [France] ; B. Dubois [France] | Apprentissage procédural et maladie de Parkinson: implication des boucles striato-frontales |
| 001036 |
Marie-Paule Muriel [France] ; Yves Agid [France] ; Etienne Hirsch [France] | Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease |
| 001042 |
J.-C. Lievens [France] ; P. Salin [France] ; A. Nieoullon [France] ; L. Kerkerian-Le Goff [France] | Nigrostriatal denervation does not affect glutamate transporter mRNA expression but subsequent levodopa treatment selectively increases GLT1 mRNA and protein expression in the rat striatum |
| 001043 |
Karine Parain [France] ; Véronique Marchand [France] ; Bernard Dumery [France] ; Etienne Hirsch [France] | Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice |
| 001062 |
Christine Dentresangle [France] ; Marion Le Cavorsin [France] ; Marc Savasta [France] ; Vincent Leviel [France] | Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra |
| 001081 |
Adrian Newman-Tancredi [France] ; Didier Cussac [France] ; Mauricette Brocco [France] ; Jean-Michel Rivet [France] ; Christine Chaput [France] ; Manuelle Touzard [France] ; Valérie Pasteau [France] ; Mark J. Millan [France] | Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra |
| 001192 |
Jeffrey H. Kordower [États-Unis] ; Marina E. Emborg [États-Unis] ; Jocelyne Bloch [États-Unis] ; Shuang Y. Ma [États-Unis] ; YAPING CHU [États-Unis] ; Liza Leventhal [États-Unis] ; Jodi Mcbride [États-Unis] ; Er-Yun Chen [États-Unis] ; Stéphane Palfi [États-Unis] ; Ben Zion Roitberg [États-Unis] ; W. Douglas Brown [États-Unis] ; James E. Holden [États-Unis, Suisse] ; Robert Pyzalski [États-Unis] ; Michael D. Taylor [Suisse] ; Paul Carvey [États-Unis] ; ZAODUNG LING [États-Unis] ; Didier Trono [Suisse] ; Philippe Hantraye [France] ; Nicole Deglon [États-Unis] ; Patrick Aebischer [États-Unis, Suisse] | Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease |
| 001219 |
Pierre Dubus [France] ; Baptiste Faucheux [France] ; Florence Boissiere [France] ; Alexis Groppi [France] ; Claude Vital [France] ; T. Anne Vital [France] ; Yves Agid [France] ; Etienne C. Hirsch [France] ; Jean Philippe Merlio [France] | Expression of Trk isoforms in brain regions and in the striatum of patients with Alzheimer's disease |
| 001254 |
| ETUDE DES CARACTERISTIQUES PHARMACOLOGIQUES ET DU RÔLE DES AUTO ET DES HETERORECEPTEURS 5-HT1B DANS LE CONTRÔLE DE L'ACTIVITE DOPAMINERGIQUE DU STRIATUM |
| 001256 |
| Développement des neurones dopaminergiques et environnement matriciel : analyse in vivo et in vitro du rôle des protéoglycannes dans la mise en place des voies mésostriatales chez le rat |
| 001303 |
C. Dentresangle [France] ; L. Veyre [France] ; D. Le Bars [France] ; C. Pierre [France] ; F. Lavenne [France] ; P. Pollak [France] ; J. Guerin [France] ; J.-C. Froment [France] ; E. Brousolle [France] | Striatal D2 dopamine receptor status in Parkinson's disease : An [18F]dopa and [11C]raclopride PET study |
| 001306 |
R. M. Marie [France] ; L. Barre [France] ; B. Dupuy [France] ; F. Viader [France] ; G. Defer [France] ; J. C. Baron [France] | Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease |
| 001325 |
M.-P. Muriel [France] ; V. Bernard [France] ; A. I. Levey [États-Unis] ; O. Laribi [France] ; D. N. Abrous [France] ; Yves Agid [France] ; B. Bloch [France] ; E. C. Hirsch [France] | Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease |
| 001332 |
M. G. Murer [Argentine] ; J. Ferrario [Argentine] ; M. Delfino [Argentine] ; G. Dziewczapolski [Argentine] ; O. S. Gershanik [Argentine] ; R. Raisman-Vozari [France] | Increased [125I]sulpiride binding in the subthalamic nucleus of rats with nigrostriatal lesions |
| 001334 |
K. Dujardin [France] ; J. F. Degreef [France] ; P. Rogelet [France] ; L. Defebvre [France] ; A. Destee [France] | Impairment of the supervisory attentional system in early untreated patients with Parkinson's disease |
| 001361 |
C. Le Bras [France] ; B. Pillon [France] ; P. Damier [France] ; B. Dubois [France] | At which steps of spatial working memory processing do striatofrontal circuits intervene in humans? |
| 001363 |
A. Sanchez-Capelo [France] ; O. Corti [France] ; J. Mallet [France] | Adenovirus-mediated over-expression of TGFβ1 in the striatum decreases dopaminergic cell survival in embryonic nigral grafts |
| 001409 |
J. Villares [France, Brésil] ; B. Faucheux [France] ; M. T. Herrero [Espagne] ; J. A. Obeso [Espagne] ; C. Duyckaerts [France] ; J.-J. Hauw [France] ; Yves Agid [France] ; E. C. Hirsch [France] | [125I]EGF binding in basal ganglia of patients with Parkinson's disease and progressive supranuclear palsy and in MPTP-treated monkeys |
| 001428 |
A. Boireau [France] ; M. Meunier [France] ; A. Imperato [France] | Ouabain-induced increase in dopamine release from mouse striatal slices is antagonized by riluzole |
| 001437 |
S. Palfi [France] ; J. P. Nguyen [France] ; P. Brugieres [France] ; C. Le Guerinel [France] ; P. Hantraye [France] ; P. Remy [France] ; S. Rostaing [France] ; G. L. Defer [France] ; P. Cesaro [France] ; Y. Keravel [France] ; M. Peschanski [France] | MRI-stereotactical approach for neural grafting in basal ganglia disorders |
| 001453 |
P. Morel [France] ; C. Tallineau [France] ; R. Pontcharraud [France] ; A. Piriou [France] ; F. Huguet [France] | Effects of 4-hydroxynonenal, a lipid peroxidation product, on dopamine transport and Na+/K+ ATPase in rat striatal synaptosomes |
| 001480 |
| Caractérisation des mécanismes mis en jeu dans les effets de la lésion de la voie nigro-striée dopaminergique sur des populations neuronales identifiées du striatum, chez le rat. Approche morphologique combinant des techniques d'immunohistochimie et d'hybridation in situ quantitatives |
| 001542 |
A. M. Bonnet [France] ; J. Pichon [France] ; M. Vidailhet [France] ; N. Gouider-Khouja [France] ; G. Robain [France] ; M. Perrigot [France] ; Yves Agid [France] | Urinary disturbances in striatonigral degeneration and Parkinson's disease: Clinical and urodynamic aspects |
| 001548 |
A. Boireau [France] ; F. Bordier [France] ; P. Dubedat [France] ; C. Peny [France] ; A. Imperato [France] | Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in mice |
| 001550 |
J. Yelnik [France] ; C. Francois [France] ; G. Percheron [France] | Spatial relationships between striatal axonal endings and pallidal neurons in macaque monkeys |
| 001566 |
F. Huguet [France] ; G. Page [France] ; P. Morel [France] ; C. Tallineau [France] ; A. Piriou [France] | MPTP toxicity in rat striatal slices : dopamine uptake alteration does not appear to be related to lipid peroxidation |
| 001571 |
M. Barkats [France] ; N. Nakao [Suède] ; E. M. Grasbon-Frodl [Suède] ; A. Bilang-Bleuel [France] ; F. Revah [France] ; J. Mallet [France] ; P. Brundin [Suède] | Intrastriatal grafts of embryonic mesencephalic rat neurons genetically modified using an adenovirus encoding human Cu/Zn superoxide dismutase |
| 001572 |
F. G. Kaddis [États-Unis] ; E. D. Clarkson ; M. J. Weber [France] ; D. J. Vandenbergh [États-Unis] ; D. M. Donovan [États-Unis] ; J. Mallet [France] ; P. Horellou [France] ; G. R. Uhl [États-Unis] ; C. R. Freed | Intrastriatal grafting of cos cells stably expressing human aromatic L-amino acid decarboxylase : Neurochemical effects |
| 001582 |
F. Coudore [France] ; F. Durif [France] ; E. Duroux [France] ; A. Eschalier [France] ; J. Fialip [France] | Effect of tolcapone on plasma and striatal apomorphine disposition in rats |
| 001584 |
P. F. Dominey [France] ; M. Jeannerod [France] | Contribution of frontostriatal function to sequence learning in Parkinson's disease: evidence for dissociable systems |
| 001593 |
J. M. Deniau [France] ; A. M. Thierry [France] | Anatomical segregation of information processing in the rat substantia nigra pars reticulata |
| 001608 |
| SYSTEME DOPAMINERGIQUE NIGRO-STRIATAL : Etude des récepteurs D1 et des transporteurs de l'amine |
| 001639 |
S. Naimi [France] ; R. Jeny [France] ; P. Hantraye [France] ; M. Peschanski [France] ; D. Riche [France] | Ontogeny of human striatal DARPP-32 neurons in fetuses and following xenografting to the adult rat brain |
| 001644 |
M. Vila [France] ; R. Levy [France] ; M.-T. Herrero ; B. Faucheux [France] ; J. A. Obeso [France] ; Yves Agid [France] ; E. C. Hirsch | Metabolic activity of the basal ganglia in Parkinsonian syndrome in human and non-human primates : A cytochrome oxidase histochemistry study |
| 001654 |
M. T. Herrero [Espagne] ; S. J. Augood [Royaume-Uni] ; H. Asensi [Espagne] ; E. C. Hirsch [France] ; Yves Agid [France] ; J. A. Obeso [Espagne] ; P. C. Emson [Royaume-Uni] | Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys |
| 001657 |
V. Blanchard [France] ; P. Anglade [France] ; G. Dziewczapolski ; M. Savasta [France] ; Yves Agid [France] ; R. Raisman-Vozari [France] | Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra |
| 001687 |
C. Wallays [France] ; A. Feve ; F. Boudghene [France] ; G. Fenelon ; A. Guillard ; J.-M. Bigot [France] | Lésions cérébrales hypoxiques aspects TDM et IRM. A propos de 20 cas. Vulnérabilité sélective du striatopallidum |
| 001704 |
R. Levy [France] ; M. Vila [France] ; M.-T. Herrero ; B. Faucheux [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Striatal expression of substance P and methionin-enkephalin genes in patients with Parkinson's disease |
| 001709 |
M. Peschanski [France] ; P. Cesaro [France] ; P. Hantraye [France] | Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease |
| 001716 |
B. Pillon [France] ; N. Gouider-Khouja ; B. Deweer ; M. Vidailhet ; C. Malapani ; B. Dubois ; Yves Agid [France] | Neuropsychological pattern of striatonigral degeneration : comparison with Parkinson's disease and progressive supranuclear palsy |
| 001729 |
M.-T. Herrero [Espagne] ; S. J. Augood ; E. C. Hirsch [France] ; F. Javoy-Agid [France] ; M. R. Luquin [Espagne] ; Yves Agid [France] ; J. A. Obeso [Espagne] ; P. C. Emson | Effects of L-DOPA on preproenkephalin and preprotackykinin gene expression in the MPTP-treated monkey striatum |
| 001737 |
B. Lannes [France] ; V. Bernard [France] ; B. Bloch [France] ; G. Micheletti [France] | Chronic treatment with dizocilpine maleate increases the number of striatal neurons expressing the D2 receptor gene |
| 001750 |
| Enzymes de protection contre les radicaux libres dans le système nerveux central de l'homme ― avec une référence particulière pour le mécanisme de la mort des neurones dopaminergiques dans la maladie de Parkinson |
| 001752 |
| Etude neuroanatomique de l'expression du récepteur dopaminergique D2 et de la préproenképhaline dans le striatum de rat après dénervation dopaminergique totale ou partielle et greffe de mésencéphale embryonnaire |
| 001769 |
B. Dubois [France] ; C. Malapani ; M. Verin ; P. Rogelet ; B. Deweer ; B. Pillon | Fonctions cognitives et noyaux gris centraux : le modèle de la maladie de Parkinson |
| 001786 |
A. Boireau [France] ; J.-M. Miquet ; P. Dubedat ; M. Meunier ; A. Doble | Riluzole and experimental parkinsonism : partial antagonism of MPP+-induced increase in striatal extracellular dopamine in rats in vivo |
| 001787 |
A. Boireau [France] ; P. Dubedat ; F. Bordier ; C. Peny ; J.-M. Miquet ; G. Durand ; M. Meunier ; A. Doble | Riluzole and experimental parkinsonism : antagonism of MPTP-induced decrease in central dopamine levels in mice |
| 001794 |
S. Lehericy [France] ; J.-P. Brandel [France] ; E. C. Hirsch [France] ; P. Anglade [France] ; J. Villares [France] ; D. Scherman [France] ; C. Duyckaerts [France] ; F. Javoy-Agid [France] ; Yves Agid [France] | Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography |
| 001796 |
J. Villares [France] ; O. Strada ; B. Faucheux ; F. Javoy-Agid ; Yves Agid [France] ; E. C. Hirsch | Loss of striatal affinity NGF binding sites in progressive supranuclear palsy but not in Parkinson's disease |
| 001807 |
P. Horellou [France] ; E. Vigne [France] ; M.-N. Castel [France] ; P. Barneoud [France] ; P. Colin [France] ; M. Perricaudet [France] ; P. Delaere [France] ; J. Mallet [France] | Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease |
| 001817 |
| Etude des transplants de neurones dopaminergiques embryonnaires dans le striatum de rat adulte. Approche multidisciplinaire: immunocytochimique, biochimique et comportementale |
| 001825 |
F. Tison [France] ; B. Duche ; P. Loiseau | Syndrome hémiparkinsonien vasculaire |
| 001859 |
I. Marey-Semper [France] ; M. Gelman ; M. Levi-Strauss | The high sensitivity to rotenone of striatal dopamine uptake suggests the existence of a constitutive metabolic deficiency in dopaminergic neurons from the substantia nigra |
| 001861 |
P. Hantraye [France] ; M. Varastet [France] ; M. Peschanski [France] ; D. Riche [France] ; P. Cesaro ; J. C. Willer ; M. Maziere [France] | Stable Parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons |
| 001863 |
P. Gaspar [France] ; A. Febvret [France] ; J. Colombo | Serotonergic sprouting in primate MTP-induced hemiparkinsonism |
| 001A11 |
M. Mavridis [France] ; A.-D. Degryse ; A. J. Lategan ; M. R. Marien ; F. C. Colpaert | Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tretrahydropyridine in monkeys : a possible role for the locus coeruleus in the progression of Parkinson's disease |
| 001A54 |
R. Raisman-Vozari ; J.-A. Girault ; S. Moussaoui ; C. Feuerstein ; P. Jenner ; C. D. Marsden ; Yves Agid [France] | Lack of change in triatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man |
| 001A61 |
S. Malessa ; E. C. Hirsch ; P. Cervera ; C. Duyckaerts ; Yves Agid [France] | Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes : a quantitative immunohistochemical study in Parkinson's disease, progressive supranuclear palsy, and striatonigral degeneration |
| 001A93 |
D. Scherman ; C. Desnos ; F. Darchen ; P. Pollak ; F. Javoy-Agid ; Yves Agid [France] | Striatal dopamine deficiency in Parkinson's disease: role of aging |
| 001A94 |
G. Renoux ; K. Biziere ; M. Renoux ; R. Steinberg ; J.-P. Kan ; J.-M. Guillaumin | Sodium diethyldithiocarbamate protects against the MPTP-induced inhibition of immune responses in mice |
| 001B83 |
P. Hantraye ; C. Loc'H ; U. Tacke ; D. Riche ; O. Stulzaft ; D. Doudet ; B. Guibert ; R. Naquet ; B. Maziere ; M. Maziere | "In vivö visualization by positron emission tomography of the progressive striatal dopamine receptor damage occurring in MPTP-intoxicated non-human primates |
